Chenbo Ding
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Redox biology and oxidative stress
- Gut microbiota and health
- Angiogenesis and VEGF in Cancer
Papers in
-
- RNA modifications and cancer 6
- Epigenetics and DNA Methylation 2
- Gut microbiota and health 2
- Angiogenesis and VEGF in Cancer 2
- Oncology 5
- Cancer Cells and Metastasis 3
- Co-authors
- Xiaobo Fan (8 shared papers)Guoqiu Wu (3 shared papers)Jihong Feng (6 shared papers)Junmin Luo (6 shared papers)Guoqiu Wu (5 shared papers)Huabing Li (6 shared papers)Longmei Li (3 shared papers)Richard Anthony Flavell (3 shared papers)
- Journals
- Science Advances (2 papers)OncoTargets and Therapy (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)BioEssays (1 paper)BMC Cancer (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Chenbo Ding
21 papers receiving 980 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 135
- Molecular Biology 527
- Aging 9
- Oncology 116
- Hepatology 29
Countries citing papers authored by Chenbo Ding
This map shows the geographic impact of Chenbo Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenbo Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenbo Ding more than expected).
Fields of papers citing papers by Chenbo Ding
This network shows the impact of papers produced by Chenbo Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenbo Ding. The network helps show where Chenbo Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenbo Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 192 | |
| 2 | 2021 | 158 | |
| 3 | 2022 | 74 | |
| 4 | 2020 | 73 | |
| 5 | 2016 | 62 | |
| 6 | 2015 | 60 | |
| 7 | 2018 | 52 | |
| 8 | 2018 | 45 | |
| 9 | 2016 | 44 | |
| 10 | 2018 | 44 | |
| 11 | 2022 | 44 | |
| 12 | 2017 | 35 | |
| 13 | 2023 | 22 | |
| 14 | Gab2 is a novel prognostic factor for colorectal cancer patients. | 2015 | 18 |
| 15 | 2023 | 17 | |
| 16 | 2019 | 15 | |
| 17 | 2019 | 15 | |
| 18 | 2017 | 8 | |
| 19 | 2020 | 5 | |
| 20 | 2023 | 4 |
About Chenbo Ding
Chenbo Ding is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Aging, having authored 22 papers that have together received 991 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), T-cell and B-cell Immunology (4 papers), Cancer Cells and Metastasis (3 papers), Epigenetics and DNA Methylation (2 papers), Gut microbiota and health (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Cancer-related molecular mechanisms research (2 papers) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Cancer Research (135 citations), Molecular Biology (527 citations), Aging (9 citations), Oncology (116 citations) and Hepatology (29 citations). Chenbo Ding has collaborated with scholars based in China and United States. Frequent co-authors include Xiaobo Fan, Guoqiu Wu, Jihong Feng, Junmin Luo, Guoqiu Wu, Huabing Li, Longmei Li, Richard Anthony Flavell, Youqiong Ye and Weina Yu. Their work appears in journals such as Science Advances, OncoTargets and Therapy, Journal of Experimental & Clinical Cancer Research, BioEssays and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.